The move adds Labcorp’s US biocompatibility, analytical testing, and preclinical research services to Namsa’s operations.

NAMSA, a global leader in medical device testing, clinical research, and regulatory consulting, is pleased to announce it has ...

With the rise of biologics, precision medicine and AI-driven drug discovery, clinical research has entered a new and complex ...

BURTON, MI, UNITED STATES, January 9, 2026 /EINPresswire.com/ -- Javelin Sciences, a pioneering certified biotechnology ...

Namsa, which is backed by Archimed, has acquired Labcorp’s US-based early development medical testing business. No financial ...

The rule, effective July 7, puts into place requirements similar to those for banks, except nonbanks do not have to make ...

Toronto man found NCR for killing his father approved for international trip despite being 'significant threat' ...

An objective look at a rifle that failed to hit its targets during testing, analyzing setup, conditions, and performance.

BURTON, MI, UNITED STATES, January 9, 2026 /EINPresswire.com/ -- Javelin Sciences, a CLIA-certified biotechnology ...

KBRA is pleased to announce the assignment of preliminary ratings to 16 classes of ACREC 2026-FL4, a managed CRE CLO securitization with the ability to reinvest principal proceeds for 24 months ...

M&G Investments (M&G) today announces that it has led a US$50 million Series C funding round for bit.bio, the Cambridge-based biotech company pioneering next-generation human cell programming ...

New regulations make this non-negotiable, but multi-die assemblies and more interactions at the edge are creating some huge ...